International research team rely on Andor Revolution XD Confocal Microscope for ground-breaking live cell studies
Belfast, UK: Prof. Manojkumar Puthenveedu of Carnegie Mellon University studies the mechanisms by which membrane trafficking controls and co-ordinates the complex signalling pathways in the brain. Despite the fact that almost all diseases can be traced to a defect in how cells respond to signals, little is known about how signalling pathways are maintained in normal cells and the changes that occur in abnormal conditions.
Using the Andor Revolution XD Confocal Microscope for live cell studies, Prof. Puthenveedu has led an international team of researchers to elucidate how signalling receptors are recycled to the cell membrane. The discovery of the mechanism by which signalling receptors travel back to the surface of the cell after activation and internalisation opens up a new class of therapeutic targets.
The team used live cell confocal fluorescence microscopy to label and image beta-2 adrenergic receptor (b2AR), the receptor for adrenaline and noradrenaline and one of a group of G protein-coupled receptors (GPCRs) pivotal to the regulation of heart and lung function, mood, cognition and memory, digestion, and the inflammatory response. After internalisation, they found that b2AR was recycled via unique domains on the endosome, which they termed Actin-Stabilized Sequence-dependent Recycling Tubule (ASSERT) domains. Rapid turnover of endosomal actin was confirmed by FRAP (fluorescence recovery after photobleaching). The ASSERT domains trap and slow down the release of receptors to provide a slower pathway compared to the faster bulk recycling pathway and could potentially be targeted by pharmaceutical agents to control diseases resulting from abnormal cell signalling.
"Confocal fluorescence microscopy has been the driver for an explosion in the study of dynamic processes in living cells, but not all systems are created equal. We have created an instrument that optimizes sensitivity, acquisition speed and specimen viability," says Mark Browne, Director of Systems at Andor. "The high optical efficiency of the Revolution XD spinning disk system allows the use of reduced laser power and, therefore, lowers the risk of phototoxicity to the specimen during long term experiments while Andor's IQ software ensures precise synchronisation of illumination, detection and scanning for unparalleled image quality and acquisition rates."
To learn more about the Revolution XD Confocal Laser Microscopy Systems and their use in live cell imaging, please visit the Andor website (http://www.andor.com).
Manojkumar A. Puthenveedu, Benjamin Lauffer, Paul Temkin, Rachel Vistein, Peter Carlton, Kurt Thorn, Jack Taunton, Orion D. Weiner, Robert G. Parton, and Mark von Zastrow. "Sequence-Dependent Sorting of Recycling Proteins by Actin-Stabilized Endosomal Microdomains," Cell 143, 761-773 (2010)
About Andor Technology
Andor is a world leader in Scientific Imaging, Spectroscopy Solutions and Microscopy Systems. Established in 1989 from Queen's University in Belfast, Northern Ireland, Andor Technology now employs over 300 people in 16 offices worldwide, distributing its portfolio of over 70 products to 10,000 customers in 55 countries.
Andor's digital cameras, designed and manufactured using pioneering techniques developed in-house, allow scientists around the world to measure light down to a single photon and capture events occurring within 1 billionth of a second. This unique capability is helping them push back the boundaries of knowledge in fields as diverse as drug discovery, toxicology analysis, medical diagnosis, food quality testing and solar energy research.
More information about Andor Technology PLC (LSE: AND) is available at the company's website (www.andor.com).
For further information, please contact Andor Technology direct or their marketing agency, NetDyaLog Limited.
Andor Technology plc.
7 Millennium Way
Springvale Business Park
Belfast BT12 7AL
+44 (0) 28 9027 0812
2 Crispin Way
Buckinghamshire SL2 3UE
+44 (0) 1753 648 140
+44 (0) 28 9027 0812
+44 (0) 1753 648 140